ESC Guidelines: CRT Gets Nod For Mild Symptoms, But Not Asymptomatic HF

New European 1guidelines provide strong support for extending cardiac resychronization therapy to a broader set of heart failure patients, but not quite the same population as an FDA panel recently recommended in the U.S